Global 3D Bioprinting for Tissue and Organ Regeneration Market

Report ID : 1336 | Published : 2022-07-20 | Pages: | Format: PDF/EXCEL

The market size of the Global 3D Bioprinting for Tissue and Organ Regeneration Market is predicted to reach 424.36 million by the year 2030 at an 15.8% CAGR during the projected period.

Diverse physiologically applicable deposition and assembling technologies, including direct writing, photolithography, microstamping, extrusion, laser writing, stereolithography, electro-printing, microfluidics, and inkjet deposition, are used in the developing field of 3D Bioprinting. Congenital diseases, deformities, and tissue damage brought on by illnesses are what fuel the desire for tissue regeneration. This factor is projected to influence how the global 3D Bioprinting for Tissue and Organ Regeneration Market develops in the coming years. With the rising use of 3D Bioprinting in the healthcare, pharmaceutical, and biotechnology markets, the global market for 3D Bioprinting for the Tissue and Organ Regeneration Market is anticipated to experience considerable expansion over the forecast period. Over the forecast period, it is also projected that the increasing use of 3D printing in cosmetic procedures and advancements in 3D Bioprinting would support the market's expansion. The expansion of public and private financing for bioprinting research initiatives has also fuelled the market's growth. The 3D Bioprinting for Tissue and Organ Regeneration Market is anticipated to be driven by the rising prevalence of diabetes, obesity, and other illnesses as a result of lifestyle changes and ageing. Over the upcoming years, the 3D Bioprinting for Tissue and Organ Regeneration Market is predicted to be compelled by the rising incidence of diabetes, obesity, and other ailments as a consequence of lifestyle changes, an ageing population, and a rise in trauma cases. Increasing healthcare expenditures and organ transplant prices are predicted to boost the market during the anticipated time frame.

Strict government regulations, high treatment costs, and the challenge of securing reimbursements and coverage for these medicines are anticipated to hinder the global market. The cost of this treatment (especially for long-term choices) may be prohibitive for certain patients, and it may have unfavourable early outcomes such as difficulties, infections, or ruptures. The lack of widely available biomaterials for the process is one of the main issues facing the 3D Bioprinting for the Tissue and Organ Regeneration industry.

Market Segmentation:

The 3D Bioprinting for the Tissue and Organ Regeneration Market is segmented on the basis of Type and Application. Based on Type, the market is segmented as Magnetic 3D Bioprinting, Laser-assisted Bioprinting, Inkjet 3D Bioprinting, and Microextrusion 3D Bioprinting. Based on Application, the market is segmented as Clinical Applications, Research Applications, Drug and Medical Research, and Others.

Based on Type, the Magnetic 3D Bioprinting segment is accounted as a major contributor in the 3D Bioprinting for Tissue and Organ Regeneration Market.

The magnetic levitation segment is anticipated to grow fastest during the forecast period. The technology's cost-effectiveness is responsible for the lucrative expansion. With its sophisticated features, increased speed, and increased accuracy, magnetic levitation technology is anticipated to eliminate more than 80.0 % of the mistakes in 3D Bioprinting. Toxicity testing, printing vascular muscles, and human cell regeneration all use these bioprinters. The healthcare sector and increased government and corporate investment in research and development projects related to magnetic levitation will drive market growth in the coming years. Technology advancement and rising demand for minimally invasive and effective treatments are the main factors driving the market growth. Additionally, increasing the effectiveness of complex cancer therapies has increased market demand, and it is anticipated that researchers will develop magnetic levitation devices that will lower the number of people who suffer from cancer and heart failure.

Based on Application, the Drug and Medical Research segment is accounted as a significant contributor in the 3D Bioprinting for Tissue and Organ Regeneration Market.

One of the reasons anticipated to drive the dynamics of the regenerative medicine business is the increase in investment by private and governmental organizations in developing the field. Additionally, one of the crucial factors anticipated to propel the market's growth during the forecast period is the existence of a robust product pipeline in stem cell and gene therapy by several research institutes and prominent market participants. However, some of the main factors projected to support the expansion of the regenerative medicine market trends throughout the forecast period are the increasing need for organ transplantation in both developed and developing nations and the commercialization of regenerative medicine. One of the key drivers of the market's expansion is the rising research of skin substitutes, grafts, bone matrix, and other tissue-engineered regenerative medicine.

The North America 3D Bioprinting for Tissue and Organ Regeneration Market holds a significant revenue share in the region.

In 2021, North America held the most significant market share for the 3D Bioprinting for Tissue and Organ Regeneration Market globally. The expansion of the healthcare industry, the increased use of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases, the rise in stem cell banking, tissue engineering, and drug discovery in the region are all factors contributing to the growth of the North American regenerative medicine market. Additionally, the availability of private and public funding, high healthcare spending, and sophisticated technology for diagnosing and treating chronic conditions encourage a higher proportion of the regional market for tissue engineering. With the availability of public funding as well as considerable investments made by private groups, the U.S. is thought to account for a sizeable portion of global revenue.

Competitive Landscape

Some of the major key players in the 3D Bioprinting for Tissue and Organ Regeneration Market are BIOLIFE4D, Organovo, Celllink, Aspect Biosystems, Cyfuse Biomedical, TeVido Biodevices, Digilab, Advanced Solutions Life Sciences, TRS – Tissue Regeneration Systems, Nscrypt, Inc, EnvisionTEC, MedPrin, Nano3D Sciences, Rokit, Cellbricks, REGEMAT 3D, Allevi, Poietis, and T&R BIOFA.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global 3D Bioprinting for Tissue and Organ Regeneration Market Snapshot

Chapter 4. Global 3D Bioprinting for Tissue and Organ Regeneration Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis

5.1. By Type & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Type:

5.2.1. Magnetic 3D Bioprinting

5.2.2. Laser-assisted Bioprinting

5.2.3. Inkjet 3D Bioprinting

5.2.4. Microextrusion 3D Bioprinting

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis

6.1. By Application & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Application:

6.2.1. Clinical Applications

6.2.2. Research Applications

6.2.3. Drug and Medical Research

6.2.4. Others

Chapter 7. 3D Bioprinting for Tissue and Organ Regeneration Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) estimates and forecasts By Type, 2020-2030

7.1.2. North America 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) estimates and forecasts By Application, 2020-2030

7.1.3. North America 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

7.2. Europe

7.2.1. Europe 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) By Type, 2020-2030

7.2.2. Europe 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) By Application, 2020-2030

7.2.3. Europe 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) by country, 2020-2030

7.3. Asia Pacific

7.3.1. Asia Pacific 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) By Type, 2020-2030

7.3.2. Asia Pacific 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) By Application, 2020-2030

7.3.3. Asia Pacific 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) by country, 2020-2030

7.4. Latin America

7.4.1. Latin America 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) By Type, (US$ Million)

7.4.2. Latin America 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) By Application, (US$ Million)

7.4.3. Latin America 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) by country, 2020-2030

7.5. Middle East & Africa

7.5.1. Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) By Type, (US$ Million)

7.5.2. Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) By Application, (US$ Million)

7.5.3. Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market revenue (US$ Million) by country, 2020-2030

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles 

8.2.1. BIOLIFE4D

8.2.2. Organovo

8.2.3. Celllink

8.2.4. Aspect Biosystems

8.2.5. Cyfuse Biomedical

8.2.6. TeVido Biodevices

8.2.7. Digilab

8.2.8. Advanced Solutions Life Sciences

8.2.9. TRS – Tissue Regeneration Systems

8.2.10. Nscrypt, Inc

8.2.11. EnvisionTEC

8.2.12. MedPrin

8.2.13. Nano3D Sciences

8.2.14. Rokit

8.2.15. Cellbricks

8.2.16. REGEMAT 3D

8.2.17. Allevi

8.2.18. Poietis

8.2.19. T&R BIOFAB

8.2.20. Other Prominent Players

Segmentation of 3D Bioprinting for Tissue and Organ Regeneration Market-

By Type

  • Magnetic 3D Bioprinting
  • Laser-assisted Bioprinting
  • Inkjet 3D Bioprinting
  • Microextrusion 3D Bioprinting

By Application

  • Clinical Applications
  • Research Applications
  • Drug and Medical Research
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa

Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Global 3D Bioprinting for Tissue and Organ Regeneration Market?

424.36 million by the year 2030

15.8% CAGR during the projected period.

Our Clients